FeesSafety
Pluang+

CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

Company Fundamentals
23 Nov 2026, 05:30 WIB
The Motley Fool Team
View Source
Bullish
CeriBell raises 2026 revenue forecast to $115-$117M, boosts hospital accounts and gross margin to 90%.

CeriBell updated its full-year 2026 revenue guidance to $115 million to $117 million, driven by increased usage per hospital account and expansion by 35 new hospital accounts. The company improved its gross margin to 90% from 88% last year, supported by new hardware capabilities and a software upgrade for delirium monitoring offered at no extra subscription cost. This strategy aims to increase headband usage without subscription friction, while the Omni platform unifies fast bedside EEG monitoring with traditional methods. With strong cash reserves and high margins, CeriBell is confident in reaching cash flow breakeven as it expands into regional health systems and government networks in 2027.

CeriBell's 2026 revenue guidance update provides context for health-sector market activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 23, 2026 04:31 WIB: out of 150 priced US health-sector stocks, 31 rose and 117 fell today. Notable movers include HIMS at USD 14.60 with a 1-day change of -8.86%, TLRY at USD 1.89 down 8.70%, and SANA at USD 1.59 down 8.62%.

More News

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology posts record $69.5M Q3 revenue, targets $200M in 2026 amid AI infrastructure growth

Gorilla Technology reported a record $69.5 million in revenue for Q3 2026, driven by expanding AI infrastructure projects and hardware deliveries. The company reduced unbilled contract assets by over 50%, improving liquidity as it shifts focus from s...

Company Fundamentals
Bullish
26 minutes ago
Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway holds steady on Apple shares despite 29% price rise and high valuation in 2026.

Berkshire Hathaway has not sold any Apple shares in 2026, even as Apple's stock price rose 29% and its price-to-earnings ratio neared 40, indicating less concern about valuation. This decision reflects confidence in Apple's strong business fundamenta...

Market News
Bullish
30 minutes ago
US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

US invests $1.6B to build domestic rare-earth supply chain with USA Rare Earth leading Texas mine development.

The U.S. government is investing $1.6 billion to develop a domestic rare-earth supply chain, aiming to reduce reliance on China. USA Rare Earth is a key player, using the funds to build out mining and processing capabilities, including developing the...

Market News
Bullish
35 minutes ago
Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences raises 2026 revenue forecast to $121-$123M, driven by biopharma demand and clinical diagnostics expansion.

Alamar Biosciences increased its full-year 2026 revenue guidance to $121-$123 million, fueled by strong demand for consumables from biopharmaceutical clients who now represent 49% of Q3 revenue. The company’s NULISA platform was selected by the U.K. ...

Company Fundamentals
Bullish
35 minutes ago
Cryptocurrency markets stabilize after $1.8B forced sell-off, Bitcoin recovers above $60K.

Cryptocurrency markets stabilize after $1.8B forced sell-off, Bitcoin recovers above $60K.

Cryptocurrency markets showed signs of stabilization on November 22 after a severe sell-off caused about $1.8 billion in forced liquidations. Bitcoin rose 1.15% to $60,785, and Ethereum gained 2.23% to $1,719, while Solana slightly declined. The sell...

Neutral
45 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App